Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
AIChE Annual MeetingAIChE Annual Meeting
Not Confirmed
Not Confirmed
02-06 November, 2025
Not Confirmed
Not Confirmed
03-06 November, 2025
Not Confirmed
Not Confirmed
03-05 November, 2025
List your booth number for exhibitions, ask us 
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
AIChE Annual MeetingAIChE Annual Meeting
Industry Trade Show
Not Confirmed
02-06 November, 2025
Industry Trade Show
Not Confirmed
03-06 November, 2025
Industry Trade Show
Not Confirmed
03-05 November, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company] 
					DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

27 Oct 2025
// BIOSPACE
https://www.biospace.com/drug-development/coya-exec-daniel-barvin-is-on-a-mission-to-end-genetic-als-and-ftd

27 Oct 2025
// BUSINESS WIRE
https://www.businesswire.com/news/home/20251027959114/en/Coya-Therapeutics-Announces-Closing-of-%2423.0-Million-Upsized-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares

24 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251024911294/en/Coya-Therapeutics-Announces-Pricing-of-%2420-Million-Upsized-Public-Offering-of-Common-Stock

23 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251023933769/en/Coya-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock

07 Oct 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-10-07/coya-therapeutics-congratulates-scientific-advisor-dr-shimon-sakaguchi-for-receiving-the-nobel-priz

29 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/coya-therapeutics-announces-completion-of-patient-enrollment-of-an-investigator-initiated-open-label-study-with-low-dose-il-2-and-ctla4-ig-combination-treatment-in-patients-with-mild-to-moderate-frontotemporal-dementia-302568487.html
ABOUT THIS PAGE
